EPA:ALINS - Euronext Paris - Matif - FR0011179886 - Common Stock - Currency: EUR
INTRASENSE SAS
EPA:ALINS (2/4/2025, 7:00:00 PM)
0.27
+0.01 (+5.47%)
The current stock price of ALINS.PA is 0.27 EUR. In the past month the price increased by 7.14%. In the past year, price decreased by -18.18%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEE.DE | VEEVA SYSTEMS INC-CLASS A | 37.14 | 36.66B | ||
COP.DE | COMPUGROUP MEDICAL SE & CO K | 47.58 | 1.23B | ||
NXU.DE | NEXUS AG | 44.26 | 1.18B | ||
EQS.PA | EQUASENS | 11.81 | 555.22M | ||
CONTX.OL | CONTEXTVISION AB | 18.14 | 393.04M | ||
GPI.MI | GPI SPA | 3 | 276.67M | ||
CGM.PA | CEGEDIM SA | 80 | 169.20M | ||
AGFB.BR | AGFA-GEVAERT NV | N/A | 138.25M | ||
ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 61.94M | ||
M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 46.96M | ||
AJ91.DE | DOCCHECK AG | 18.65 | 45.38M |
Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie and currently employs 74 full-time employees. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.
INTRASENSE SAS
1231 Avenue du Mondial 98
Montpellier OCCITANIE FR
Employees: 74
Company Website: https://intrasense.fr/
Investor Relations: https://www.intrasense.fr/investors/
Phone: 33467130130
The current stock price of ALINS.PA is 0.27 EUR.
The exchange symbol of INTRASENSE SAS is ALINS and it is listed on the Euronext Paris - Matif exchange.
ALINS.PA stock is listed on the Euronext Paris - Matif exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ALINS.PA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ALINS.PA.
ALINS.PA does not pay a dividend.
ALINS.PA will report earnings on 2025-02-06.
ALINS.PA does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).
ChartMill assigns a technical rating of 1 / 10 to ALINS.PA. When comparing the yearly performance of all stocks, ALINS.PA is a bad performer in the overall market: 89.11% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to ALINS.PA. While ALINS.PA seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months ALINS.PA reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 6.75% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -34.24% | ||
ROE | -49.1% | ||
Debt/Equity | 0.16 |
ChartMill assigns a Buy % Consensus number of 40% to ALINS.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.